Surveillance of paediatric exposures to liquid laundry detergent pods in Italy

Laura Settimi1, Felice Giordano2, Laura Lauria1

  • 1National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy.

Insights

Laundry detergent pods pose a greater risk to children than traditional detergents. Opaque packaging significantly reduced pod exposures, indicating a potential safety improvement strategy for laundry products.

Area of Science:

  • Pediatric Toxicology
  • Consumer Product Safety
  • Environmental Health

Background:

  • Paediatric exposure to laundry detergents is a significant concern.
  • Laundry detergent pods present unique risks compared to traditional formulations.

Purpose of the Study:

  • To analyze paediatric exposures to laundry detergent pods versus traditional detergents in Italy.
  • To investigate changes in exposure trends following packaging modifications.

Main Methods:

  • Retrospective analysis of pediatric cases (<5 years) exposed to laundry detergents from September 2010 to June 2015.
  • Data sourced from the National Poison Control Center in Milan.
  • Comparison of clinical outcomes and exposure rates between pod and traditional detergent groups.

Main Results:

  • Exposure to pods resulted in higher hospitalization rates (68% vs 42%), clinical effects (75% vs 22%), and moderate/high severity outcomes (13% vs <1%) compared to traditional detergents.
  • Opaque outer packaging for pods led to a sharp decline in exposure rates (from 1.03 to 0.36 cases/day).
  • Odds of clinical effects were significantly higher for pod exposures (OR=10.8), with increased severity in children under 1 year (OR=3.9).

Conclusions:

  • Laundry detergent pods are demonstrably more dangerous than traditional detergents for paediatric exposure.
  • Reducing pod visibility through opaque packaging is an effective preventive measure.
  • Continued efforts are necessary to enhance the safety of laundry detergent products.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K